Back to News
Market Impact: 0.28

3 Investment Management Stocks to Look At Despite Industry Challenges

Source: zacks.com

Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst InsightsCredit & Bond MarketsM&A & RestructuringTechnology & Innovation
3 Investment Management Stocks to Look At Despite Industry Challenges

The Zacks Investment Management industry has underperformed over two years, losing 17.3% versus gains of 30.7% for the S&P 500 and 19% for the Finance sector; current-year industry earnings estimates have fallen 7.4% since November 2025-end. The article highlights fee compression, rising technology and compliance costs, and private-credit concerns, offset by ETF and wealth-management demand. BlackRock, Ameriprise and Invesco show growth in AUM or revenues, while Ameriprise reported $9.3 billion in Q3 asset-management outflows and Invesco’s 2026 earnings estimate was revised lower.

Analysis

The key distinction is revenue quality, not AUM growth: passive and ETF inflows can expand assets while lowering the fee yield, so headline flows may overstate earnings momentum. Scale helps absorb distribution, technology and compliance costs, but it does not eliminate mix-driven revenue dilution. BlackRock has the strongest potential to monetize scale across ETFs and alternatives; the offset is that acquisitions increase execution demands and add exposure to private-market fundraising and valuation cycles. Ameriprise is more directly levered to advisor productivity and client assets, making it a cleaner wealth-management expression, though asset-management outflows are a meaningful counterweight. Invesco’s margin improvement is encouraging, but downward earnings revisions alongside strong flows suggest investors should verify that cost actions translate into durable per-share earnings rather than just AUM growth.

The industry discount should not by itself be read as a catalyst: if earnings expectations keep falling, a lower multiple can persist. Over days, flows and market beta likely dominate; over 1–3 months, earnings revisions and fee yields are better discriminators. Over 6–18 months, the test is whether AI and platform spending produces measurable productivity without sacrificing margins, and whether private-credit concerns impair fundraising or valuations. The contrarian angle is that passive growth is not uniformly bearish for incumbents: large firms can capture share and consolidate distribution, but the winners will be those that convert flows into stable net revenue. The thesis weakens if fee yield and operating margins deteriorate despite inflows, or if advisor transfers and retention disappoint.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.15

Ticker Sentiment

AMP0.35
BLK0.65
IVZ0.45

Key Decisions for Investors

  • Consider a modest, market- and beta-aware long AMP / short IVZ pair as a 1–3 month earnings-revision trade, not a structural call: AMP’s estimate direction is more supportive, while IVZ’s margin progress needs confirmation in per-share earnings. Reassess after the next reports; exit if AMP’s advisor-asset transfer momentum weakens or IVZ revisions stabilize and its margin gains persist.
  • Keep BLK on a pullback watchlist rather than chase recent relative strength. Add only if organic flows convert into resilient fee revenue and acquisition integration costs do not erode operating leverage; reduce exposure if private-market fundraising or reported fee yield weakens materially.
  • Track quarterly organic flows separately from market appreciation, effective fee yield, operating margin, technology expense growth, and private-markets fundraising/valuation disclosures. Rising AUM with falling fee yield or margin is a falsifier of the bullish scale thesis.
  • Treat the industry valuation discount as a watch item, not a standalone long signal. A further downgrade in earnings estimates or a deterioration in broad equity markets could overwhelm any multiple-reversion case.

More News

From AllMind Research

Browse all research